Commit To Purchase Clovis Oncology At $50, Earn 20.8% Annualized Using Options
February 18, 2014 at 11:26 AM EST
Investors eyeing a purchase of Clovis Oncology (CLVS) shares, but tentative about paying the going market price of $69.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $50 strike, which has a bid at the time of this writing of $4.30..